Publication | Closed Access

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

Diabetic RetinopathyOcular DiseaseOphthalmologyExperimental OphthalmologyDiabetic Macular OedemaGlaucomaMedicine48-Week Results